Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAUORA: Cytisine versus Varenicline for Smoking Cessation
NCT02957786Phase 3Completed
- Sponsor
- The University of Auckland
- Start
- Sep 2017
- Primary completion
- Oct 2019
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of cytisinicline in Tobacco Use Disorder (TUD), sponsored by The University of Auckland. Started Sep 2017; status: completed.
02
Drugs
cytisinicline
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02957786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02957786.